12:00 AM
 | 
Dec 16, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Rosetta Kidney Cancer Test regulatory update

Rosetta Genomics Ltd. (NASDAQ:ROSG), Rehovot, Israel
Product: Rosetta Kidney Cancer Test, miRview kidney
Business: Diagnostic
Rosetta said the New...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >